Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 625.00 | 278.42 | 875.00 | 762.25 | 1.1479 | 1.1992 |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 1045.00 | 762.25 | 1.3709 | 1.4850 | |
| BT-20 | Etoposide | 0.1 | uM | 3 | 625.00 | 278.42 | 1053.00 | 762.25 | 1.3814 | 1.4981 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 3 | 625.00 | 278.42 | 951.00 | 762.25 | 1.2476 | 1.3289 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 625.00 | 278.42 | 866.00 | 762.25 | 1.1361 | 1.1836 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 625.00 | 278.42 | 777.00 | 762.25 | 1.0194 | 1.0266 |
| BT-20 | NVP-TAE684 | 0.031623 | uM | 3 | 625.00 | 278.42 | 926.00 | 762.25 | 1.2148 | 1.2866 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 625.00 | 278.42 | 855.00 | 762.25 | 1.1217 | 1.1645 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 625.00 | 278.42 | 713.00 | 762.25 | 0.9354 | 0.9101 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 625.00 | 278.42 | 1118.00 | 762.25 | 1.4667 | 1.6032 |
| BT-20 | PLX-4720 | 1 | uM | 3 | 625.00 | 278.42 | 838.00 | 762.25 | 1.0994 | 1.1348 |
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 625.00 | 278.42 | 901.00 | 762.25 | 1.1820 | 1.2440 |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 739.00 | 762.25 | 0.9695 | 0.9578 | |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 555.00 | 762.25 | 0.7281 | 0.6076 | |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 532.00 | 762.25 | 0.6979 | 0.5615 | |
| BT-20 | 0 | uM | 3 | 625.00 | 278.42 | 736.00 | 762.25 | 0.9656 | 0.9523 | |
| BT-20 | Etoposide | 0.01 | uM | 3 | 625.00 | 278.42 | 725.00 | 762.25 | 0.9511 | 0.9322 |
| BT-20 | Etoposide | 0.31623 | uM | 3 | 625.00 | 278.42 | 654.00 | 762.25 | 0.8580 | 0.7999 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 625.00 | 278.42 | 925.00 | 762.25 | 1.2135 | 1.2849 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 625.00 | 278.42 | 934.00 | 762.25 | 1.2253 | 1.3002 |
| BT-20 | Nilotinib | 0.1 | uM | 3 | 625.00 | 278.42 | 940.00 | 762.25 | 1.2332 | 1.3104 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 625.00 | 278.42 | 371.00 | 762.25 | 0.4867 | 0.2185 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 625.00 | 278.42 | 925.00 | 762.25 | 1.2135 | 1.2849 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 625.00 | 278.42 | 1076.00 | 762.25 | 1.4116 | 1.5355 |
| BT-20 | Nilotinib | 10 | uM | 3 | 625.00 | 278.42 | 801.00 | 762.25 | 1.0508 | 1.0694 |